APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Subcloning Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global DNA Subcloning Services Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchDNA Subcloning Services Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Subcloning Services Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal DNA Subcloning Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Subcloning Services Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal DNA Subcloning Services Market Analysis and Forecast 2026-2032245 pages · $4,950 USD

Market perspective

The global DNA Subcloning Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for DNA Subcloning Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DNA Subcloning Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DNA Subcloning Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the DNA Subcloning Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the DNA Subcloning Services market include Sydlabs, GenScript, Thermo Fisher Scientific, OriGene, Eton Bioscience, Synbio Technologies, Eurofins Genomics, Tsingke Biotech and MCLAB, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global DNA Subcloning Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DNA Subcloning Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DNA Subcloning Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global DNA Subcloning Services market.

DNA Subcloning Services Segment by Company

Sydlabs

GenScript

Thermo Fisher Scientific

OriGene

Eton Bioscience

Synbio Technologies

Eurofins Genomics

Tsingke Biotech

MCLAB

Innoprot

Applied Biological Materials Inc. (abm)

BaseGene

Gencefebio

FIVEphoton Biochemicals

1st BASE

DNA Subcloning Services Segment by Type

Restriction Enzyme-based Subcloning

PCR-based Subcloning

Other

DNA Subcloning Services Segment by Application

Biotechnology

Pharmaceuticals

Basic Research

Others

DNA Subcloning Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global DNA Subcloning Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the DNA Subcloning Services key companies, revenue, market share, and recent developments.

3. To split the DNA Subcloning Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions DNA Subcloning Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DNA Subcloning Services significant trends, drivers, influence factors in global and regions.

6. To analyze DNA Subcloning Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Subcloning Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Subcloning Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Subcloning Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Subcloning Services industry.

Chapter 3: Detailed analysis of DNA Subcloning Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of DNA Subcloning Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of DNA Subcloning Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DNA Subcloning Services Industry Trends Table 2. DNA Subcloning Services Industry Drivers Table 3. DNA Subcloning Services Industry Opportunities and Challenges Table 4. DNA Subcloning Services Industry Restraints Table 5. Global DNA Subcloning Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DNA Subcloning Services Revenue Share by Company (2021-2026) Table 7. Global DNA Subcloning Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global DNA Subcloning Services Key Company Manufacturing Base & Headquarters Table 9. Global DNA Subcloning Services Company, Product Type & Application Table 10. Global DNA Subcloning Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global DNA Subcloning Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Restriction Enzyme-based Subcloning Table 15. Significant Companies of PCR-based Subcloning Table 16. Significant Companies of Other Table 17. Global DNA Subcloning Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global DNA Subcloning Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global DNA Subcloning Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global DNA Subcloning Services Sales Value Share by Type (2021-2026) Table 21. Global DNA Subcloning Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Biotechnology Table 23. Significant Companies of Pharmaceuticals Table 24. Significant Companies of Basic Research Table 25. Significant Companies of Others Table 26. Global DNA Subcloning Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global DNA Subcloning Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global DNA Subcloning Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global DNA Subcloning Services Sales Value Share by Application (2021-2026) Table 30. Global DNA Subcloning Services Sales Value Share by Application (2027-2032) Table 31. Global DNA Subcloning Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global DNA Subcloning Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global DNA Subcloning Services Sales Value Share by Region (2021-2026) Table 34. Global DNA Subcloning Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global DNA Subcloning Services Sales Value Share by Region (2027-2032) Table 36. Global DNA Subcloning Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global DNA Subcloning Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global DNA Subcloning Services Sales Value Market Share by Country (2021-2026) Table 39. Global DNA Subcloning Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global DNA Subcloning Services Sales Value Market Share by Country (2027-2032) Table 41. Sydlabs Company Information Table 42. Sydlabs Business Overview Table 43. Sydlabs DNA Subcloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Sydlabs DNA Subcloning Services Product Portfolio Table 45. Sydlabs Recent Development Table 46. GenScript Company Information Table 47. GenScript Business Overview Table 48. GenScript DNA Subcloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. GenScript DNA Subcloning Services Product Portfolio Table 50. GenScript Recent Development Table 51. Thermo Fisher Scientific Company Information Table 52. Thermo Fisher Scientific Business Overview Table 53. Thermo Fisher Scientific DNA Subcloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Thermo Fisher Scientific DNA Subcloning Services Product Portfolio Table 55. Thermo Fisher Scientific Recent Development Table 56. OriGene Company Information Table 57. OriGene Business Overview Table 58. OriGene DNA Subcloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. OriGene DNA Subcloning Services Product Portfolio Table 60. OriGene Recent Development Table 61. Eton Bioscience Company Information Table 62. Eton Bioscience Business Overview Table 63. Eton Bioscience DNA Subcloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Eton Bioscience DNA Subcloning Services Product Portfolio Table 65. Eton Bioscience Recent Development Table 66. Synbio Technologies Company Information Table 67. Synbio Technologies Business Overview Table 68. Synbio Technologies DNA Subcloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Synbio Technologies DNA Subcloning Services Product Portfolio Table 70. Synbio Technologies Recent Development Table 71. Eurofins Genomics Company Information Table 72. Eurofins Genomics Business Overview Table 73. Eurofins Genomics DNA Subcloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Eurofins Genomics DNA Subcloning Services Product Portfolio Table 75. Eurofins Genomics Recent Development Table 76. Tsingke Biotech Company Information Table 77. Tsingke Biotech Business Overview Table 78. Tsingke Biotech DNA Subcloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Tsingke Biotech DNA Subcloning Services Product Portfolio Table 80. Tsingke Biotech Recent Development Table 81. MCLAB Company Information Table 82. MCLAB Business Overview Table 83. MCLAB DNA Subcloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. MCLAB DNA Subcloning Services Product Portfolio Table 85. MCLAB Recent Development Table 86. Innoprot Company Information Table 87. Innoprot Business Overview Table 88. Innoprot DNA Subcloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Innoprot DNA Subcloning Services Product Portfolio Table 90. Innoprot Recent Development Table 91. Applied Biological Materials Inc. (abm) Company Information Table 92. Applied Biological Materials Inc. (abm) Business Overview Table 93. Applied Biological Materials Inc. (abm) DNA Subcloning Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Applied Biological Materials Inc. (abm) DNA Subcloning Services Product Portfolio Table 95. Applied Biological Materials Inc. (abm) Recent Development Table 96. BaseGene Company Information Table 97. BaseGene Business Overview Table 98. BaseGene DNA Subcloning Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. BaseGene DNA Subcloning Services Product Portfolio Table 100. BaseGene Recent Development Table 101. Gencefebio Company Information Table 102. Gencefebio Business Overview Table 103. Gencefebio DNA Subcloning Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Gencefebio DNA Subcloning Services Product Portfolio Table 105. Gencefebio Recent Development Table 106. FIVEphoton Biochemicals Company Information Table 107. FIVEphoton Biochemicals Business Overview Table 108. FIVEphoton Biochemicals DNA Subcloning Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. FIVEphoton Biochemicals DNA Subcloning Services Product Portfolio Table 110. FIVEphoton Biochemicals Recent Development Table 111. 1st BASE Company Information Table 112. 1st BASE Business Overview Table 113. 1st BASE DNA Subcloning Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. 1st BASE DNA Subcloning Services Product Portfolio Table 115. 1st BASE Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. DNA Subcloning Services Product Image Figure 2. Global DNA Subcloning Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Subcloning Services Market Size (2021-2032) & (US$ Million) Figure 4. Global DNA Subcloning Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Restriction Enzyme-based Subcloning Image Figure 8. PCR-based Subcloning Image Figure 9. Other Image Figure 10. Global DNA Subcloning Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global DNA Subcloning Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global DNA Subcloning Services Sales Value Share by Type (2021-2032) Figure 13. Biotechnology Image Figure 14. Pharmaceuticals Image Figure 15. Basic Research Image Figure 16. Others Image Figure 17. Global DNA Subcloning Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global DNA Subcloning Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global DNA Subcloning Services Sales Value Share by Application (2021-2032) Figure 20. Global DNA Subcloning Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global DNA Subcloning Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America DNA Subcloning Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America DNA Subcloning Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe DNA Subcloning Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe DNA Subcloning Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific DNA Subcloning Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific DNA Subcloning Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America DNA Subcloning Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America DNA Subcloning Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa DNA Subcloning Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa DNA Subcloning Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt DNA Subcloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Restriction Enzyme-based Subcloning
  • PCR-based Subcloning
  • Other
Applications
  • Biotechnology
  • Pharmaceuticals
  • Basic Research
  • Others
Companies covered
  • Sydlabs
  • GenScript
  • Thermo Fisher Scientific
  • OriGene
  • Eton Bioscience
  • Synbio Technologies
  • Eurofins Genomics
  • Tsingke Biotech
  • MCLAB
  • Innoprot
  • Applied Biological Materials Inc. (abm)
  • BaseGene
  • Gencefebio
  • FIVEphoton Biochemicals
  • 1st BASE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global DNA Subcloning Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global DNA Subcloning Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 DNA Subcloning Services Market Dynamics
  1. 2.1 DNA Subcloning Services Industry Trends
  2. 2.2 DNA Subcloning Services Industry Drivers
  3. 2.3 DNA Subcloning Services Industry Opportunities and Challenges
  4. 2.4 DNA Subcloning Services Industry Restraints
3 DNA Subcloning Services Market by Company
  1. 3.1 Global DNA Subcloning Services Company Revenue Ranking in 2025
  2. 3.2 Global DNA Subcloning Services Revenue by Company (2021-2026)
  3. 3.3 Global DNA Subcloning Services Company Ranking (2024-2026)
  4. 3.4 Global DNA Subcloning Services Company Manufacturing Base and Headquarters
  5. 3.5 Global DNA Subcloning Services Company Product Type and Application
  6. 3.6 Global DNA Subcloning Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global DNA Subcloning Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 DNA Subcloning Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 DNA Subcloning Services Market by Type
  1. 4.1 DNA Subcloning Services Type Introduction
  2. 4.1.1 Restriction Enzyme-based Subcloning
  3. 4.1.2 PCR-based Subcloning
  4. 4.1.3 Other
  5. 4.2 Global DNA Subcloning Services Sales Value by Type
  6. 4.2.1 Global DNA Subcloning Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global DNA Subcloning Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global DNA Subcloning Services Sales Value Share by Type (2021-2032)
5 DNA Subcloning Services Market by Application
  1. 5.1 DNA Subcloning Services Application Introduction
  2. 5.1.1 Biotechnology
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Basic Research
  5. 5.1.4 Others
  6. 5.2 Global DNA Subcloning Services Sales Value by Application
  7. 5.2.1 Global DNA Subcloning Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global DNA Subcloning Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global DNA Subcloning Services Sales Value Share by Application (2021-2032)
6 DNA Subcloning Services Regional Value Analysis
  1. 6.1 Global DNA Subcloning Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DNA Subcloning Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global DNA Subcloning Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global DNA Subcloning Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America DNA Subcloning Services Sales Value (2021-2032)
  7. 6.3.2 North America DNA Subcloning Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe DNA Subcloning Services Sales Value (2021-2032)
  10. 6.4.2 Europe DNA Subcloning Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific DNA Subcloning Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific DNA Subcloning Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America DNA Subcloning Services Sales Value (2021-2032)
  16. 6.6.2 South America DNA Subcloning Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa DNA Subcloning Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa DNA Subcloning Services Sales Value Share by Country, 2025 VS 2032
7 DNA Subcloning Services Country-level Value Analysis
  1. 7.1 Global DNA Subcloning Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DNA Subcloning Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global DNA Subcloning Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global DNA Subcloning Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt DNA Subcloning Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt DNA Subcloning Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt DNA Subcloning Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sydlabs
  2. 8.1.1 Sydlabs Company Information
  3. 8.1.2 Sydlabs Business Overview
  4. 8.1.3 Sydlabs DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sydlabs DNA Subcloning Services Product Portfolio
  6. 8.1.5 Sydlabs Recent Developments
  7. 8.2 GenScript
  8. 8.2.1 GenScript Company Information
  9. 8.2.2 GenScript Business Overview
  10. 8.2.3 GenScript DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GenScript DNA Subcloning Services Product Portfolio
  12. 8.2.5 GenScript Recent Developments
  13. 8.3 Thermo Fisher Scientific
  14. 8.3.1 Thermo Fisher Scientific Company Information
  15. 8.3.2 Thermo Fisher Scientific Business Overview
  16. 8.3.3 Thermo Fisher Scientific DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Scientific DNA Subcloning Services Product Portfolio
  18. 8.3.5 Thermo Fisher Scientific Recent Developments
  19. 8.4 OriGene
  20. 8.4.1 OriGene Company Information
  21. 8.4.2 OriGene Business Overview
  22. 8.4.3 OriGene DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 OriGene DNA Subcloning Services Product Portfolio
  24. 8.4.5 OriGene Recent Developments
  25. 8.5 Eton Bioscience
  26. 8.5.1 Eton Bioscience Company Information
  27. 8.5.2 Eton Bioscience Business Overview
  28. 8.5.3 Eton Bioscience DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eton Bioscience DNA Subcloning Services Product Portfolio
  30. 8.5.5 Eton Bioscience Recent Developments
  31. 8.6 Synbio Technologies
  32. 8.6.1 Synbio Technologies Company Information
  33. 8.6.2 Synbio Technologies Business Overview
  34. 8.6.3 Synbio Technologies DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Synbio Technologies DNA Subcloning Services Product Portfolio
  36. 8.6.5 Synbio Technologies Recent Developments
  37. 8.7 Eurofins Genomics
  38. 8.7.1 Eurofins Genomics Company Information
  39. 8.7.2 Eurofins Genomics Business Overview
  40. 8.7.3 Eurofins Genomics DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eurofins Genomics DNA Subcloning Services Product Portfolio
  42. 8.7.5 Eurofins Genomics Recent Developments
  43. 8.8 Tsingke Biotech
  44. 8.8.1 Tsingke Biotech Company Information
  45. 8.8.2 Tsingke Biotech Business Overview
  46. 8.8.3 Tsingke Biotech DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Tsingke Biotech DNA Subcloning Services Product Portfolio
  48. 8.8.5 Tsingke Biotech Recent Developments
  49. 8.9 MCLAB
  50. 8.9.1 MCLAB Company Information
  51. 8.9.2 MCLAB Business Overview
  52. 8.9.3 MCLAB DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MCLAB DNA Subcloning Services Product Portfolio
  54. 8.9.5 MCLAB Recent Developments
  55. 8.10 Innoprot
  56. 8.10.1 Innoprot Company Information
  57. 8.10.2 Innoprot Business Overview
  58. 8.10.3 Innoprot DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Innoprot DNA Subcloning Services Product Portfolio
  60. 8.10.5 Innoprot Recent Developments
  61. 8.11 Applied Biological Materials Inc. (abm)
  62. 8.11.1 Applied Biological Materials Inc. (abm) Company Information
  63. 8.11.2 Applied Biological Materials Inc. (abm) Business Overview
  64. 8.11.3 Applied Biological Materials Inc. (abm) DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Applied Biological Materials Inc. (abm) DNA Subcloning Services Product Portfolio
  66. 8.11.5 Applied Biological Materials Inc. (abm) Recent Developments
  67. 8.12 BaseGene
  68. 8.12.1 BaseGene Company Information
  69. 8.12.2 BaseGene Business Overview
  70. 8.12.3 BaseGene DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BaseGene DNA Subcloning Services Product Portfolio
  72. 8.12.5 BaseGene Recent Developments
  73. 8.13 Gencefebio
  74. 8.13.1 Gencefebio Company Information
  75. 8.13.2 Gencefebio Business Overview
  76. 8.13.3 Gencefebio DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Gencefebio DNA Subcloning Services Product Portfolio
  78. 8.13.5 Gencefebio Recent Developments
  79. 8.14 FIVEphoton Biochemicals
  80. 8.14.1 FIVEphoton Biochemicals Company Information
  81. 8.14.2 FIVEphoton Biochemicals Business Overview
  82. 8.14.3 FIVEphoton Biochemicals DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 FIVEphoton Biochemicals DNA Subcloning Services Product Portfolio
  84. 8.14.5 FIVEphoton Biochemicals Recent Developments
  85. 8.15 1st BASE
  86. 8.15.1 1st BASE Company Information
  87. 8.15.2 1st BASE Business Overview
  88. 8.15.3 1st BASE DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 1st BASE DNA Subcloning Services Product Portfolio
  90. 8.15.5 1st BASE Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst